BoydSense

Allez Health Raises $60M for CGM Biosensor

Allez Health has raised $60 million in a Series A for its continuous glucose monitoring (CGM) biosensor platform for connected digital health platforms.

BoydSense Raises $7.5M for Breathable Glucose Monitor

BoydSense's new prototype allows diabetics and pre-diabetics to check their blood glucose levels by breathing into a device.